Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Interest Expenses (2022 - 2023)

Historic Interest Expenses for Candel Therapeutics (CADL) over the last 2 years, with Q4 2023 value amounting to -$4.5 million.

  • Candel Therapeutics' Interest Expenses fell 88148.79% to -$4.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$2.6 million, marking a year-over-year decrease of 26938.64%. This contributed to the annual value of -$2.1 million for FY2024, which is 1946.05% up from last year.
  • Candel Therapeutics' Interest Expenses amounted to -$4.5 million in Q4 2023, which was down 88148.79% from $669000.0 recorded in Q3 2023.
  • Candel Therapeutics' Interest Expenses' 5-year high stood at $669000.0 during Q3 2023, with a 5-year trough of -$4.5 million in Q4 2023.